A compendium of extracellular vesicle biogenesis inhibitors: From bench to bedside
This review explores a decade of research on extracellular vesicles (EVs), detailing their biogenesis and roles in health and disease. It emphasizes EVs' relevance for potential medical applications covering various conditions such as cancer, neurodegeneration, inflammation, and infectious diseases, bridging experimental findings with clinical ...
Stefano Vecchione +2 more
wiley +1 more source
The Battle Against Pertussis: Discovery of Endogenous Human Proteins and Peptides as Toxin-Inhibitors. [PDF]
Lietz S, Barth H.
europepmc +1 more source
Insights into the complexity of SARS-CoV-2 M<sup>pro</sup> inhibition: Ebselen and its derivatives impair dimerisation of the enzyme. [PDF]
Fabbian S +9 more
europepmc +1 more source
Proteinaceous Toxins in the Mucus and Proboscis of the Ribbon Worm <i>Cephalothrix</i> cf. <i>simula</i> (Palaeonemertea: Nemertea). [PDF]
Kuznetsov VG +3 more
europepmc +1 more source
RET receptor tyrosine kinase architecture, assemblies, and activation. [PDF]
Zol-Hanlon M, McDonald NQ.
europepmc +1 more source
Microbial proteases and endothelial barrier disruption in sepsis: A neglected nexus. [PDF]
Rao SS +6 more
europepmc +1 more source
A Novel Covalent Inhibitor Fragment for the SARS-CoV-2 Main Protease Identified by Target-Specific Deep Learning. [PDF]
Zhou W +4 more
europepmc +1 more source
Murine monoclonal antibodies against the major cysteine proteinase inhibitors of human biological fluids, cystatin C and kininogen, were produced. The cystatin C antibody, HCC3, with a Ka of 2times107 l/mol, increased the inhibition of papain by cystatin
Isleifur Olafsson +2 more
exaly +3 more sources
Related searches:
Human cysteine proteinase inhibitors
Scandinavian Journal of Clinical and Laboratory Investigation, 1988Magnus Abrahamson
exaly +2 more sources

